Toggle light / dark theme

A Korean research team has developed a lithium-ion battery that is flexible enough to be stretched. Dr. Jeong Gon Son’s research team at the Photo-Electronic Hybrids Research Center at the Korea Institute of Science and Technology (KIST) announced that they had constructed a high-capacity, stretchable lithium-ion battery. The battery was developed by fabricating a structurally stretchable electrode consisting solely of electrode materials and then assembling with a stretchable gel electrolyte and stretchable packaging.

Rapid technological advancements in the electronics industry have led to a fast-growing market for high-performance wearable devices, such as smart bands and body-implantable electronic devices, such as pacemakers. These advancements have considerably increased the need for energy storage devices to be designed in flexible and stretchable forms that mimic human skin and organs.

However, it is very difficult to impart stretchability to the because the solid inorganic material occupies most of the volume, and other components such as current collectors and separators must also be made stretchable. In addition, the problem of liquid electrolyte leakage under deformation must also be solved, as well as the problem of leaking liquid .

Maria became the very first COVID-19 patient to use Stem Cell Neurotherapy for COVID-19. In about 5 days, she will began to feel the healing effects of generating new lung cells which will eliminate her breathing problems.

We repurposed some tools from the Stem Cell Therapy for Cancer/Brain Tumor. Those tools are T-Cells, B-Cells, and Natural Killer Cells. Instead of programming those cancer killing cells to attack cancer cells, we have programmed them to seek out, identify, attack, and destroy all the Coronavirus cells in the entire body.

Stem Cell Neurotherapy sends therapeutic messages, e.g., “your stem cells are transforming into new cells for the lungs, liver, and kidneys” to the DNA inside the nucleus of stem cells. Inside the nucleus, the DNA receives the message and transmits it to the RNA, which translates the message into genetic code.

The genes inside the stem cells transmit the coded message to the proteins, which are converted by the mitochondria into ATP, which provides the energy for the coded message to transform the stem cells into a new set of lung cells, as well as new cells for the kidneys and liver.

These new cells in the lungs, kidneys, and liver will replace the cells that were infected by the COVID-19 virus. This results in the elimination of the coughing, fever, headaches, diarrhea, and breathing problems.

Final edition of stem cell neurotherapy for COVID-19.

We have just finished the Final Edition of Stem Cell Neurotherapy for COVID-19. We repurposed some tools from the Stem Cell Therapy for Cancer/Brain Tumor. Those tools are T-Cells, B-Cells, and Natural Killer Cells. Instead of programming those cancer killing cells to attack cancer cells, we have programmed them to seek out, identify, attack, and destroy all the Coronavirus cells in the entire body.

We still program the stem cells to transform themselves into new cells for the lungs, liver, and kidneys to replace those cells infected by the Coronavirus.

So, stem cells have a dual function in this therapy:

A. Destruction of the Coronavirus cells

The first study on vitamin D and COVID-19 was released as a preprint on April 23, and a second study was released as a preprint on April 26. Here’s what we can learn from the second study. The first study, which I reported on a few days ago, focused on disease severity, while the second one, which I’m reporting on here, focused on mortality.

The Results

The electronic health records of 780 laboratory-confirmed COVID-19 cases from the government hospitals of Indonesia between March 2 and April 24 was searched for data on vitamin D status prior to admission, age, sex, preexisting conditions, and mortality. Vitamin D status was classified as normal (≥30 ng/mL), insufficient (21−29 ng/mL), or deficient (≤20 ng/mL).